Aarti Pharmalabs (NSE:AARTIPHARM) Total Liabilities : ₹9,165 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Aarti Pharmalabs Total Liabilities?

Aarti Pharmalabs's Total Liabilities for the quarter that ended in Mar. 2025 was ₹9,165 Mil.

Aarti Pharmalabs's quarterly Total Liabilities declined from Sep. 2024 (₹9,197.85 Mil) to Dec. 2024 (₹0.00 Mil) but then increased from Dec. 2024 (₹0.00 Mil) to Mar. 2025 (₹9,164.99 Mil).

Aarti Pharmalabs's annual Total Liabilities increased from Mar. 2023 (₹6,855.37 Mil) to Mar. 2024 (₹8,250.66 Mil) and increased from Mar. 2024 (₹8,250.66 Mil) to Mar. 2025 (₹9,164.99 Mil).

Aarti Pharmalabs Total Liabilities Historical Data

The historical data trend for Aarti Pharmalabs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Pharmalabs Total Liabilities Chart

Aarti Pharmalabs Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Total Liabilities

0.22

6,534.22

6,855.37

8,250.66

9,164.99

Aarti Pharmalabs Quarterly Data
	Mar21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial									8,250.66	-	9,197.85	-	9,164.99

Aarti Pharmalabs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aarti Pharmalabs's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6570.495	+	(1152.245	+	1442.247
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	9,165

Total Liabilities	=	Total Assets (A: Mar. 2025 )	-	Total Equity (A: Mar. 2025 )
	=	29064.051	-	19899.064
	=	9,165

Aarti Pharmalabs's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6570.495	+	(1152.245	+	1442.247
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	9,165

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	29064.051	-	19899.064
	=	9,165

Aarti Pharmalabs Total Liabilities Related Terms

Thank you for viewing the detailed overview of Aarti Pharmalabs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Pharmalabs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Pharmalabs Ltd (NSE:AARTIPHARM) » Definitions » Total Liabilities

Traded in Other Exchanges

543748:India

Address

Mulund Goregaon Link Road, 2nd floor, 204, Udyog Kshetra, Mulund West, Mumbai, MH, IND, 400080

Website

https://www.aartipharmalabs.com

Aarti Pharmalabs Ltd manufactures pharmaceuticals and nutraceuticals with a footprint. It manufactures Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, and xanthine derivatives in India. It also offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. Geographically, the company generates maximum revenue from its customers located outside India.

Aarti Pharmalabs Headlines

No Headlines